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Human Recombination Hotspot Detection, by Li et
al. (p. 628)
Recombination occurs throughout the genome at speciﬁc
sites, termed “hotspots,” that separate genomic DNA into
regions of high linkage disequilibrium (LD). An under-
standing of where these hotspots occur not only provides
insight into the mechanisms behind recombination but
may also affect association studies that incorporate LD.
Sperm-typing techniques can be used to look at recom-
bination on a ﬁne scale, but they are experimentally in-
tensive and slow. To make the search for hotspots more
efﬁcient, researchers have developed computational
means to predict recombinationhotspots frompopulation
genotype data. The algorithms vary in their approach and
differ in their ability to correctly identify hotspots, their
need for phased data, their false-positive rate, and their
computational cost. Previously, when the recombination
site predictions of the top detection methods were com-
pared with the hotspots identiﬁed experimentally by
sperm typing, the most accurate technique was the slowest
and was unable to handle unphased data. Here, Li et al.
develop TWPLL (truncated, weighted pairwise log-likeli-
hood), a method that is faster and can be applied to phased
and unphased data. After demonstrating the speed and ac-
curacy of TWPLL, the authors use their method on the
ENCODE regions to predict new hotspots.
Bayesian Haplotype Analysis, by Morris (p. 679)
In the search for associations between polymorphismsand
complex diseases, many methods analyzing multilocus
haplotypes are being developed and used. There has been
a tendency among researchers to use these algorithms to
ﬁt their data to multiplicative models but to ignore dom-
inance effects, because of concern over the penalties as-
sociated with additional testing. Here, Morris presents an
approach that accommodates dominance effects and al-
lows for the identiﬁcation of associations that would not
have been observed if a nonmultiplicative model had not
been incorporated. He expands on his earlier development
of a method that uses common ancestry to cluster marker
SNP haplotypes, via a Bayesian partition model, into
clades, in an effort to minimize lost information. Com-
parisons of the new algorithm, GENEBPMv2, with other
methods demonstrate how power can be gained, without
too much cost, by allowing for dominance. The usefulness
of this approach is presented with an analysis of genotype
data of CYP2D6, a gene involved in drug metabolism.
HLA-B Matching Increases Schizophrenia Risk, by
Palmer et al. (p. 710)
The etiology of schizophrenia is considered to be complex,
with susceptibility to the disease being inﬂuenced by ge-
netic and environmental factors. Previous studies have
suggested that complications during pregnancy may con-
tribute to the risk of a child’s developing neurodevelop-
mental disorders. One such complication, Rhesus incom-
patibility, occurs when maternal antibodies are produced
against paternal red-blood-cell antigens. This maternal re-
sponse can cause signiﬁcant risk to the developing fetus. In
contrast, studies of the human leukocyte antigen (HLA)
locus support the hypothesis that the production of ma-
ternal antibodies to paternal HLAs may actually improve
the chances of a healthy pregnancy. Palmer et al. therefore
predicted that if the maternal HLA alleles match those of
the developing fetus, complications may arise that would
increase the risk of schizophrenia in the child. The au-
thors searched for an association between HLA matching
and the risk of schizophrenia-related disorders and found
signiﬁcant evidence that matching of HLA-B alleles in-
creases the risk of schizophrenia in female offspring.
Two Founding Events for LRRK2 G2019S, by
Zabetian et al. (p. 752)
The G2019S mutation in LRRK2 is a frequent cause of
autosomal dominant Parkinson disease in populations of
European descent. A number of studies that have looked
at probands from Europe, the Middle East, and North Af-
rica have found the mutation on a single founder hap-
lotype. When analyses were then done to estimate the
time since the most recent common ancestor, it was dif-
ﬁcult to reconcile the time with the known historical data
of the populations involved. To learn more about the re-
gion and to potentially resolve the discrepancies associ-
ated with the evolution of the G2019S mutation, Zabetian
et al. reassessed the polymorphisms in the region and
chose ﬁve new markers to evaluate in a new set of cases
and controls. These studies revealed two distinct haplo-
types that are predicted to have arisen from two indepen-
dent founders. The authors also used their new data to
recalculate how long ago the families with haplotype 1
may have shared a common ancestor. The approach they
used yields a time that more easily ﬁts with the migra-
tional patterns of the people studied.
SAMD9 Mutation in NFTC, by Topaz et al. (p. 759)
Familial tumoral calcinosis (FTC) is a life-threatening con-
dition characterized by the deposition of calciﬁed tumors.
ii The American Journal of Human Genetics Volume 79 October 2006 www.ajhg.org
When associated with hyperphosphatemia, FTC is caused
by mutations in GALNT3 or FGF23, but Topaz et al. de-
scribe ﬁve FTC-affected families with normal phosphate
levels and no mutations in either of the known disease
genes. Gene-mapping studies led to the identiﬁcation of
an SAMD9 mutation that segregated in the affected in-
dividuals of all ﬁve analyzed families. The function of the
protein encoded by SAMD9 has not yet been elucidated,
but the mRNA is expressed in a number of tissues, in-
cluding skin. Expression of the SAMD9 transcript was
found to be elevated in patient ﬁbroblasts, as well as in
cells transfected withmutant SAMD9. The authors studied
the effect of the mutation at the protein level by creating
fusion proteins with green ﬂuorescent protein. Whereas
the wild-type protein localized to the cytoplasm, no mu-
tant SAMD9 was observed. It is thought that a major dif-
ference between the normophosphatemic (NFTC) and hy-
perphosphatemic (HFTC) forms of FTC involves the way
the calcinosis is acquired. There are indications that NFTC
develops as a response to inﬂammation or injury and that
HFTC is a result of deposits forming because of improper
calcium and phosphate metabolism. The differences be-
tween the two forms of the disease may help to determine
the function of SAMD9.
This Month on the Cover
In 1959, Jerome Lejeune et al. published their chromo-
somal analysis of nine children with Down syndrome and
noted that each had 47 chromosomes instead of the nor-
mal 46 (C R Hebd Seances Acad Sci 248:1721–1722). The
recognition of the association between the extra chro-
mosome and Down syndrome is often considered a critical
moment in the dawn of clinical cytogenetics. Recall from
the March AJHG 2006 cover that the manuscript reporting
that normal cells have 46 chromosomes had just been
published in 1956 by Tijo and Levan (Hereditas 42:1–6).
On the cover, the presence of an extra copy of chro-
mosome 21 in a patient’s cell determines that he or she
has Down syndrome. Here, the same chromosomes are
organized into a numbered karyotype, so that the patient’s
three copies of chromosome 21 can be easily observed.
Special thanks to Joana Carvalho Da Costa and Azra H.
Ligon, Brigham and Women’s Hospital, Department of
Pathology, Clinical Cytogenetics Laboratory, Boston, for
the metaphase and karyotype images.
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